Extrathymically generated regulatory T cells control mucosal TH2 inflammation


A balance between pro- and anti-inflammatory mechanisms at mucosal interfaces, which are sites of constitutive exposure to microbes and non-microbial foreign substances, allows for efficient protection against pathogens yet prevents adverse inflammatory responses associated with allergy, asthma and intestinal inflammation1. Regulatory T (Treg) cells prevent systemic and tissue-specific autoimmunity and inflammatory lesions at mucosal interfaces. These cells are generated in the thymus (tTreg cells) and in the periphery (induced (i)Treg cells), and their dual origin implies a division of labour between tTreg and iTreg cells in immune homeostasis. Here we show that a highly selective blockage in differentiation of iTreg cells in mice did not lead to unprovoked multi-organ autoimmunity, exacerbation of induced tissue-specific autoimmune pathology, or increased pro-inflammatory responses of T helper 1 (TH1) and TH17 cells. However, mice deficient in iTreg cells spontaneously developed pronounced TH2-type pathologies at mucosal sites—in the gastrointestinal tract and lungs—with hallmarks of allergic inflammation and asthma. Furthermore, iTreg-cell deficiency altered gut microbial communities. These results suggest that whereas Treg cells generated in the thymus appear sufficient for control of systemic and tissue-specific autoimmunity, extrathymic differentiation of Treg cells affects commensal microbiota composition and serves a distinct, essential function in restraint of allergic-type inflammation at mucosal interfaces.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Impaired iT reg cell generation and altered composition of the peripheral T reg cell population in CNS1-deficient mice.
Figure 2: Paucity of iT reg cells results in T H 2 inflammation in the gastrointestinal tract.
Figure 3: iT reg cell deficiency leads to T H 2 type gastrointestinal pathology and altered microbial communities.
Figure 4: Unprovoked asthma-like airway pathology in CNS1-deficient mice.


  1. 1

    Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306 (2011)

    ADS  CAS  Article  Google Scholar 

  2. 2

    Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008)

    CAS  Article  Google Scholar 

  3. 3

    Chen, W. et al. Conversion of peripheral CD4+CD25 naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198, 1875–1886 (2003)

    CAS  Article  Google Scholar 

  4. 4

    Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nature Immunol. 9, 194–202 (2008)

    CAS  Article  Google Scholar 

  5. 5

    Zheng, Y. et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463, 808–812 (2010)

    ADS  CAS  Article  Google Scholar 

  6. 6

    Hill, J. A. et al. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29, 758–770 (2008)

    CAS  Article  Google Scholar 

  7. 7

    Nolting, J. et al. Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines. J. Exp. Med. 206, 2131–2139 (2009)

    CAS  Article  Google Scholar 

  8. 8

    Xu, L. et al. Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33, 313–325 (2010)

    CAS  Article  Google Scholar 

  9. 9

    Liu, Y. et al. A critical function for TGF-β signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nature Immunol. 9, 632–640 (2008)

    ADS  CAS  Article  Google Scholar 

  10. 10

    Ouyang, W., Beckett, O., Ma, Q. & Li, M. O. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32, 642–653 (2010)

    CAS  Article  Google Scholar 

  11. 11

    Curotto de Lafaille, M. A. & Lafaille, J. J. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 30, 626–635 (2009)

    CAS  Article  Google Scholar 

  12. 12

    Mucida, D. et al. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 115, 1923–1933 (2005)

    CAS  Article  Google Scholar 

  13. 13

    Bautista, J. L. et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nature Immunol. 10, 610–617 (2009)

    CAS  Article  Google Scholar 

  14. 14

    Leung, M. W., Shen, S. & Lafaille, J. J. TCR-dependent differentiation of thymic Foxp3+ cells is limited to small clonal sizes. J. Exp. Med. 206, 2121–2130 (2009)

    CAS  Article  Google Scholar 

  15. 15

    Moran, A. E. et al. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208, 1279–1289 (2011)

    CAS  Article  Google Scholar 

  16. 16

    Lathrop, S. K. et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 478, 250–254 (2011)

    ADS  CAS  Article  Google Scholar 

  17. 17

    Komatsu, N. et al. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl Acad. Sci. USA 106, 1903–1908 (2009)

    ADS  CAS  Article  Google Scholar 

  18. 18

    Hori, S. Regulatory T cell plasticity: beyond the controversies. Trends Immunol. 32, 295–300 (2011)

    CAS  Article  Google Scholar 

  19. 19

    Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunol. 10, 1000–1007 (2009)

    CAS  Article  Google Scholar 

  20. 20

    Rubtsov, Y. P. et al. Stability of the regulatory T cell lineage in vivo. Science 329, 1667–1671 (2010)

    ADS  CAS  Article  Google Scholar 

  21. 21

    Josefowicz, S. Z. & Rudensky, A. Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616–625 (2009)

    CAS  Article  Google Scholar 

  22. 22

    Gottschalk, R. A., Corse, E. & Allison, J. P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 207, 1701–1711 (2010)

    CAS  Article  Google Scholar 

  23. 23

    Kretschmer, K. et al. Inducing and expanding regulatory T cell populations by foreign antigen. Nature Immunol. 6, 1219–1227 (2005)

    CAS  Article  Google Scholar 

  24. 24

    Tian, L. et al. Foxp3 regulatory T cells exert asymmetric control over murine helper responses by inducing Th2 cell apoptosis. Blood 118, 1845–1853 (2011)

    CAS  Article  Google Scholar 

  25. 25

    Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986–991 (2009)

    ADS  CAS  Article  Google Scholar 

  26. 26

    Koch, M. A. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunol. 10, 595–602 (2009)

    CAS  Article  Google Scholar 

  27. 27

    Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351–356 (2009)

    ADS  CAS  Article  Google Scholar 

  28. 28

    Wang, Y., Su, M. A. & Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337–348 (2011)

    CAS  Article  Google Scholar 

  29. 29

    Wohlfert, E. A. et al. GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice. J. Clin. Invest. 121, 4503–4515 (2011)

    CAS  Article  Google Scholar 

  30. 30

    Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006)

    ADS  Article  Google Scholar 

  31. 31

    Stromnes, I. M. & Goverman, J. M. Active induction of experimental allergic encephalomyelitis. Nature Protocols 1, 1810–1819 (2006)

    CAS  Article  Google Scholar 

  32. 32

    Burich, A. et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G764–G778 (2001)

    CAS  Article  Google Scholar 

  33. 33

    Ubeda, C. et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120, 4332–4341 (2010)

    CAS  Article  Google Scholar 

  34. 34

    Nossa, C. W. et al. Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J. Gastroenterol. 16, 4135–4144 (2010)

    CAS  Article  Google Scholar 

  35. 35

    Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009)

    CAS  Article  Google Scholar 

  36. 36

    Edgar, R. C. et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194–2200 (2011)

    CAS  Article  Google Scholar 

  37. 37

    Magurran, A. E. Measuring Biological Diversity (Blackwell, 2004)

    Google Scholar 

  38. 38

    Wang, Q. et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261–5267 (2007)

    CAS  Article  Google Scholar 

  39. 39

    Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010)

    CAS  Article  Google Scholar 

Download references


We thank T. Tedder for depleting CD20 antibody, R. Tudor for assistance interpreting lung pathology, P. DeRoos for assistance with Ig ELISA assays, B. Johnson for immunohistochemical expertise, Y. Chen for assistance with airway measurements, and E. Pamer, L. Lipuma, A. Gobourne and R. Khanin for help with analysis of intestinal microbiota. This work was supported by NIH MSTP grant GM07739 and NINDS grant 1F31NS073203-01 (R.E.N.), Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from Department of Microbiology and Immunology, Keio University School of Medicine (T.C.) and NIH grant R37 AI034206 (A.Y.R.). A.Y.R is an investigator with the Howard Hughes Medical Institute.

Author information




S.Z.J., R.E.N. and H.Y.K. performed experiments and analysed data, with assistance from T.C. for tissue Ig ELISA experiments, and P.T. for immunohistochemistry and histopathology analysis. D.T.U., S.Z.J., R.E.N., H.Y.K, and A.Y.R designed and interpreted AHR experiments. Y.Z. generated CNS1- mice. S.Z.J., R.E.N. and A.Y.R. designed experiments and wrote the paper.

Corresponding author

Correspondence to Alexander Y. Rudensky.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-21 with legends. (PDF 5434 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Josefowicz, S., Niec, R., Kim, H. et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482, 395–399 (2012). https://doi.org/10.1038/nature10772

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing